1. A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death. Issue 3 (25th January 2020) Authors: Briand, François; Heymes, Christophe; Bonada, Lucile; Angles, Thibault; Charpentier, Julie; Branchereau, Maxime; Brousseau, Emmanuel; Quinsat, Marjolaine; Fazilleau, Nicolas; Burcelin, Rémy; Sulpice, Thierry Journal: Clinical and translational science Issue: Volume 13:Issue 3(2020) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗